XTX Topco’s ANI Pharmaceuticals ANIP Stock Holding History

XTX Topco’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.45M	Buy	29,591 +1,066	+4%	+$85.5K	0.03%	918
2026 Q1	$2.19M	Buy	28,525 +12,782	+81%	+$998K	0.04%	761
2025 Q4	$1.24M	Buy	+15,743	New	+$1.36M	0.03%	875
2025 Q3	–	Sell	-9,111	Closed	-$594K	–	2528
2025 Q2	$594K	Buy	+9,111	New	+$593K	0.02%	979
2025 Q1	–	Sell	-18,029	Closed	-$997K	–	2374
2024 Q4	$997K	Buy	+18,029	New	+$1.04M	0.08%	307
2024 Q3	–	Sell	-3,254	Closed	-$207K	–	2059
2024 Q2	$207K	Buy	+3,254	New	+$211K	0.02%	1214
2024 Q1	–	Sell	-7,210	Closed	-$398K	–	1807
2023 Q4	$398K	Buy	+7,210	New	+$397K	0.09%	403
2023 Q2	–	Sell	-5,763	Closed	-$229K	–	1393
2023 Q1	$229K	Buy	+5,763	New	+$243K	0.05%	853

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

GACM

Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

XTX Topco's ANIP Position: Q2 2026 in Review

XTX Topco increased its ANI Pharmaceuticals (ANIP) stake by 3.7% in Q2 2026, buying an estimated $85.5K and bringing the position to 29,591 shares worth $2.45M. The position accounts for 0.03% of the portfolio, ranked #918.

XTX Topco first reported a position in ANIP in Q1 2023 and has held it in 8 quarters since. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

XTX Topco held 29,591 shares of ANI Pharmaceuticals worth $2.45M as of Q2 2026.
XTX Topco bought 1,066 ANI Pharmaceuticals shares in Q2 2026, an estimated $85.5K.
ANI Pharmaceuticals made up 0.03% of XTX Topco's portfolio in Q2 2026, its #918 holding.
XTX Topco first reported a position in ANI Pharmaceuticals in Q1 2023 and has held it in 8 quarters since.
307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.